Recent Progress in the Identification and Development of InhA Direct Inhibitors of Mycobacterium tuberculosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 3, 2010-03 ,pp. : 182-193

Bentham Science Publishers

Access to resources Recommend Favorite

Progress on the Discovery of Inhibitors of InhA, the FAS II Enoyl-ACP Reductase TB Drug Discovery Targeted on InhA

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 539-546

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Metabolism in Mycobacterium tuberculosis as a Target for Drug Development

By  

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis

By  

Medicinal Chemistry, Vol. 5, Iss. 2, 2009-03 ,pp. : 197-207

Bentham Science Publishers

Access to resources Recommend Favorite

Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria

By Ramos Daniela Fernandes   Almeida da Silva Pedro Eduardo  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 48, Iss. 3, 2010-03 ,pp. : 260-263

Informa Healthcare

Access to resources Recommend Favorite